- Home
- EH vs GPCR Comparison
EH vs GPCR Comparison
Compare EH & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EH
- GPCR
- Stock Information
- Founded
- EH 2014
- GPCR 2016
- Country
- EH China
- GPCR United States
- Employees
- EH N/A
- GPCR N/A
- Industry
- EH Military/Government/Technical
- GPCR
- Sector
- EH Industrials
- GPCR
- Exchange
- EH Nasdaq
- GPCR Nasdaq
- Market Cap
- EH 1.2B
- GPCR 1.1B
- IPO Year
- EH 2019
- GPCR 2023
- Fundamental
- Price
- EH $17.06
- GPCR $20.79
- Analyst Decision
- EH Strong Buy
- GPCR Strong Buy
- Analyst Count
- EH 3
- GPCR 7
- Target Price
- EH $24.80
- GPCR $76.17
- AVG Volume (30 Days)
- EH 1.4M
- GPCR 761.9K
- Earning Date
- EH 08-21-2025
- GPCR 08-07-2025
- Dividend Yield
- EH N/A
- GPCR N/A
- EPS Growth
- EH N/A
- GPCR N/A
- EPS
- EH N/A
- GPCR N/A
- Revenue
- EH $57,950,389.00
- GPCR N/A
- Revenue This Year
- EH $102.39
- GPCR N/A
- Revenue Next Year
- EH $59.66
- GPCR N/A
- P/E Ratio
- EH N/A
- GPCR N/A
- Revenue Growth
- EH 167.93
- GPCR N/A
- 52 Week Low
- EH $10.40
- GPCR $13.22
- 52 Week High
- EH $29.76
- GPCR $47.48
- Technical
- Relative Strength Index (RSI)
- EH 51.74
- GPCR 38.49
- Support Level
- EH $16.62
- GPCR $20.70
- Resistance Level
- EH $18.07
- GPCR $23.67
- Average True Range (ATR)
- EH 0.77
- GPCR 1.24
- MACD
- EH 0.11
- GPCR -0.08
- Stochastic Oscillator
- EH 62.45
- GPCR 13.93
About EH EHang Holdings Limited ADS
EHang Holdings Ltd is an urban air mobility (UAM) technology platform company. It focuses on making safe, autonomous, eco-friendly air mobility accessible to everyone. EHang provides customers in various industries with unmanned aerial vehicle (UAV) systems and solutions: air mobility (including passenger transportation and logistics), smart city management, and aerial media solutions. EHang's EH216-S has received a production certificate and standard airworthiness certificate for passenger-carrying pilotless eVTOL aircraft issued by the Civil Aviation Administration of China. The group continues to explore the boundaries of the sky to make flying technologies benefit life in smart cities.
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.